Copper tripeptide-1, a tiny, naturally occurring protein fragment that carries copper, is sold mainly in scalp serums to preserve or regrow hair. Evidence in people is thin: one small eyebrow study showed modest gains, and scalp results come only from mixtures with proven hair drugs. Topical use appears low-risk; larger risks come from injected products and from replacing proven treatments. Best understood as a low-risk, low-certainty add-on. (Full Review)

Protocol

Standard topical regimen

1–2% serum, about 1 mL

Leave-on scalp serum or foam on dry scalp, once or twice daily; at least 6 months before judging effect

Eyebrow regimen

2% serum, twice daily

Applied to the brow for 12 weeks in the controlled trial; same approach used for thinning eyebrows

Best time of day

Evening, after washing

Undisturbed overnight contact; morning use works if minoxidil occupies the evening slot

Time to effect

Eyebrow hair

12 weeks

Changes appeared only at 12 weeks in the controlled trial

Scalp hair

3–6 months

Minimum observation window of consistent use, as with other hair-growth agents

Defining success

6 months

Stable or reduced shedding and a measurable rise in density or hair diameter; no change suggests the peptide is not contributing

Benefits

Medium: Increased eyebrow hair count and thickness

Low: Scalp hair regrowth in hereditary pattern hair loss; faster healing after hair transplant; improved scalp condition in flaky scalp; reduced facial wrinkling

Speculative: Local suppression of the male hormone that shrinks susceptible follicles; less inflammation and scarring around follicles

Contraindications

Wilson disease (any stage) or other diagnosed copper-overload disorders, especially for injectable use

Documented copper allergy (positive copper sulfate patch test, ≥1+ reaction at 72–96 hours)

Pregnancy or breastfeeding, for injectable forms (no safety data for any route)

Active scalp infection, open wounds or uncontrolled inflammatory scalp disease at the application site

Active skin cancer on the scalp or face at the application site (theoretical concern)

Key Interactions

Prescription copper-lowering drugs (penicillamine, trientine): caution; injected or high-exposure use opposes Wilson disease treatment

Topical retinoids (vitamin A–derived skin drugs; tretinoin, adapalene): monitor; additive irritation and increased peptide penetration

Topical minoxidil: monitor; combined formulations can increase scalp dryness and itch

Over-the-counter strong acids and oxidizers (glycolic or salicylic acid peels, benzoyl peroxide): caution; can break the copper complex and irritate

Topical vitamin C (L-ascorbic acid) and chelator-containing products (EDTA, ethylenediaminetetraacetic acid, a metal-binding additive): caution; can reduce or strip the bound copper

Supplements with copper or high-dose zinc: monitor; oral copper adds to copper load for injectors; zinc above 40 mg daily can deplete copper

Additive hair-growth supplements and topicals (rosemary oil, caffeine, saw palmetto): monitor; stacking obscures which agent works and increases irritation risk

Microneedling, laser and scalp injections: caution; increase peptide penetration and reactions

Risk & Side Effects

Medium: Procedure-related scalp reactions with injected or microneedled mixtures

Low: Allergic contact dermatitis to copper; hyperpigmentation after microneedling; hair-loss progression from delaying proven therapy

Speculative: Immune reactions and impurities from injectable gray-market peptide; copper accumulation or local oxidative stress; growth stimulation of existing skin tumors; temporary shedding after starting; local irritation from the serum or layered actives

Monitoring

Marker	Target	Why
Ferritin	50–100 ng/mL	Iron stores; deficiency drives shedding
TSH (thyroid-stimulating hormone)	0.5–2.5 mIU/L	Thyroid function
25-hydroxyvitamin D	40–60 ng/mL	Vitamin D status linked to follicle cycling
Serum zinc	90–120 µg/dL	Zinc deficiency causes shedding
Serum copper	80–120 µg/dL	Baseline copper status; essential for injectors
Ceruloplasmin	20–35 mg/dL	Main copper-carrying protein
ALT (alanine aminotransferase)	Below 25 U/L	Liver health for injectors
Scalp hair density (trichoscopy, magnified scalp imaging)	No established target; track change from own baseline	Objective regrowth measure

Cadence: Baseline photographs, trichoscopy where available and blood tests; photographs and trichoscopy at 3 and 6 months, then every 6–12 months. Ferritin, vitamin D and thyroid repeated at 6 months only if baseline was abnormal. Injected use: copper, ceruloplasmin and liver enzymes every 3–6 months.

Qualitative Assessment

Daily shedding (hairs on pillow, in shower drain or comb)
Visible scalp through the part or crown in consistent photographs
Eyebrow fullness and gaps
Scalp itch, redness, flaking or burning after application
Hair texture and shaft thickness by feel
Personal satisfaction with appearance

Copper Tripeptide-1 for Hair Regrowth

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment